Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
An increasing number of children suffer from the consequences of maternal drug exposure during pregnancy, and Cannabis is one of the most frequently used substances. This motivated the study, published in the EMBO Journal, conducted in mice and human brain tissue, to decipher the molecular basis of how the major psychoactive component from Cannabis called delta-9-tetrahydrocannabinol or THC affects brain development of the unborn foetus.
The study highlights that consuming Cannabis during pregnancy clearly results in defective development of nerve cells of the cerebral cortex, the part of the brain that orchestrates higher cognitive functions and drives memory formation. In particular, THC negatively impacts if and how the structural platform and conduit for communication between nerve cells, the synapses and axons, will develop and function. Researchers also identified Stathmin-2 as a key protein target for THC action, and its loss is characterized as a reason for erroneous nerve growth. It is stressed that Cannabis exposure in experimental models precisely coincided with the fetal period when nerve cells form connections amongst each other.
According to study leader Professor Tibor Harkany, who shares his time between Karolinska Institutet and the Medical University Vienna in Austria, these developmental deficits may evoke life-long modifications to the brain function of those affected. Even though not all children who have been exposed to Cannabis will suffer immediate and obvious deficits, Professor Harkany warns that relatively subtle damage can significantly increase the risk of delayed neuropsychiatric diseases.
"Even if THC only would cause small changes its effect may well be sufficient to sensitize the brain to later stressors or diseases to provoke neuropsychiatric illnesses in those affected in the future", says Professor Harkany. "This concerns also the medical use of Cannabis, which should be avoided during pregnancy."
In addition to researchrs from Sweden and Austria, researchers from the US, Germany, Finland and the UK took part in the study. The work was financed with grants from the Scottish Universities Life Science Alliance, the Swedish Research Council, Hjärnfonden, the Novo Nordisk Foundation, the Wellcome Trust, and the National Institutes of Health.
'Miswiring the brain delta-9-tetra-hydro-cannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway', Giuseppe Tortoriello, Claudia V. Morris, Alan Alpar, Janos Fuzik, Sally L. Shirran, Daniela Calvigioni, Erik Keimpema, Catherine H. Botting, Kirstin Reinecke, Thomas Herdegen, Michael Courtney, Yasmin L. Hurd and Tibor Harkany, EMBO Journal, online 27 January 2014.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Alcohol / Addiction / Illegal Drugs category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Institutet, Karolinska. "Fetal brain development jeopardized by cannabis use during pregnancy." Medical News Today. MediLexicon, Intl., 29 Jan. 2014. Web.
10 Mar. 2014. <http://www.medicalnewstoday.com/releases/271782>
Institutet, K. (2014, January 29). "Fetal brain development jeopardized by cannabis use during pregnancy." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/271782.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.